Durable natural killer cell responses after heterologous two-dose Ebola vaccination

Durable natural killer cell responses after heterologous two-dose Ebola vaccination

Abstract Natural killer (NK) cells are implicated among immune effectors after vaccination against viral pathogens, including Ebola virus. The two-dose heterologous Ebola virus vaccine regimen, adenovirus type 26.ZEBOV followed by modified vaccinia Ankara-BN-Filo (EBOVAC2 consortium, EU Innovative M...

Full description

Bibliographic Details
Main Authors: Helen R. Wagstaffe, Giada Susannini, Rodolphe Thiébaut, Laura Richert, Yves Lévy, Viki Bockstal, Jeroen N. Stoop, Kerstin Luhn, Macaya Douoguih, Eleanor M. Riley, Christine Lacabaratz, Martin R. Goodier
Format: Article
Language:English
Published: Nature Portfolio 2021-01-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-021-00280-0

Internet

https://doi.org/10.1038/s41541-021-00280-0

Similar Items